Reduced nicotine reward in obesity: cross-comparison in human and mouse

Psychopharmacology (Berl). 2005 Jul;180(2):306-15. doi: 10.1007/s00213-005-2167-9. Epub 2005 Feb 18.

Abstract

Rationale: Tobacco use and obesity lead to significant morbidity and mortality.

Objective: This study was conducted to investigate the factors maintaining smoking behavior in lean and obese individuals by utilizing a mouse/human cross-validation model of nicotine reward.

Methods: In humans, a cigarette choice paradigm was used to examine the relative reinforcing value of nicotine in obese and non-obese smokers. Conditioned place preference (CPP) for nicotine was assessed in mice fed standard low fat rodent chow and mice rendered obese by a high fat diet.

Results: In humans, obese smokers self-administered nicotine via cigarettes significantly less often than non-obese smokers and showed attenuated hedonic effects of nicotine-containing cigarettes compared to denicotinized cigarettes. Similarly, mice exposed to a high fat diet did not exhibit nicotine CPP, relative to control mice. mRNA levels for mu-opiate and leptin receptors were also downregulated in the ventral tegmental area of these mice.

Conclusions: Together, these studies provide the first evidence for reduced nicotine reward in obese subjects and suggest that this may be mediated by dietary influences on the endogenous opioid system.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cyclic AMP / physiology
  • Female
  • Humans
  • Male
  • Mice
  • Nicotine / administration & dosage*
  • Obesity / psychology*
  • RNA, Messenger / analysis
  • Receptors, Cell Surface / genetics
  • Receptors, Leptin
  • Receptors, Opioid, mu / genetics
  • Reward*
  • Smoking / psychology*
  • Ventral Tegmental Area / physiology

Substances

  • RNA, Messenger
  • Receptors, Cell Surface
  • Receptors, Leptin
  • Receptors, Opioid, mu
  • Nicotine
  • Cyclic AMP